Bank of America
IMUX icon

Bank of America’s Immunic IMUX Stock Holding History

Bank of America’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
14,387
+14,369
+79,828% +$129K ﹤0.01% 5430
2025
Q4 		$95 Buy
18
+1
+6% +$7 ﹤0.01% 6830
2025
Q3 		$150 Sell
17
-87
-84% -$767 ﹤0.01% 7777
2025
Q2 		$725 Sell
104
-1,853
-95% -$17K ﹤0.01% 7591
2025
Q1 		$21.3K Buy
1,957
+4
+0.2% +$43 ﹤0.01% 6955
2024
Q4 		$19.5K Sell
1,953
-14
-0.7% -$176 ﹤0.01% 6850
2024
Q3 		$32.5K Sell
1,967
-275
-12% -$3.92K ﹤0.01% 6652
2024
Q2 		$24.9K Sell
2,242
-9,620
-81% -$120K ﹤0.01% 6684
2024
Q1 		$157K Buy
11,862
+3,174
+37% +$41.2K ﹤0.01% 6015
2023
Q4 		$130K Sell
8,688
-1,851
-18% -$22.7K ﹤0.01% 6268
2023
Q3 		$155K Sell
10,539
-4,826
-31% -$92.8K ﹤0.01% 6039
2023
Q2 		$386K Buy
15,365
+6,312
+70% +$106K ﹤0.01% 5444
2023
Q1 		$135K Sell
9,053
-33,612
-79% -$624K ﹤0.01% 6127
2022
Q4 		$597K Buy
42,665
+41,879
+5,328% +$1.14M ﹤0.01% 5246
2022
Q3 		$25K Buy
786
+285
+57% +$11.9K ﹤0.01% 6950
2022
Q2 		$17K Sell
501
-368
-42% -$23.6K ﹤0.01% 7228
2022
Q1 		$98K Sell
869
-442
-34% -$51.2K ﹤0.01% 6878
2021
Q4 		$125K Buy
1,311
+687
+110% +$61.9K ﹤0.01% 6770
2021
Q3 		$54K Buy
624
+88
+16% +$8.66K ﹤0.01% 7009
2021
Q2 		$65K Buy
536
+5
+0.9% +$692 ﹤0.01% 6711
2021
Q1 		$84K Sell
531
-707
-57% -$120K ﹤0.01% 6464
2020
Q4 		$189K Buy
1,238
+537
+77% +$96.4K ﹤0.01% 5637
2020
Q3 		$130K Sell
701
-338
-33% -$55.4K ﹤0.01% 5539
2020
Q2 		$126K Buy
1,039
+782
+304% +$79.6K ﹤0.01% 5554
2020
Q1 		$16K Buy
+257
New +$20.7K ﹤0.01% 6239
2019
Q4 		– Sell
-3
Closed -$249 – 7220
2019
Q3 		$0 Sell
3
-158
-98% -$21.2K ﹤0.01% 7352
2019
Q2 		$18K Buy
161
+136
+544% +$17.9K ﹤0.01% 6595
2019
Q1 		$2K Sell
25
-24
-49% -$2.11K ﹤0.01% 6908
2018
Q4 		$3K Buy
49
+2
+4% +$234 ﹤0.01% 6839
2018
Q3 		$5K Buy
47
+26
+124% +$67.9K ﹤0.01% 6826
2018
Q2 		$59K Sell
21
-6
-22% -$13.9K ﹤0.01% 6049
2018
Q1 		$73K Buy
27
+3
+13% +$6.88K ﹤0.01% 5889
2017
Q4 		$57K Buy
24
+18
+300% +$39.8K ﹤0.01% 6009
2017
Q3 		$13K Sell
6
-28
-82% -$36.5K ﹤0.01% 6445
2017
Q2 		$40K Buy
34
+17
+100% +$22.7K ﹤0.01% 5963
2017
Q1 		$28K Sell
17
-2
-11% -$3.66K ﹤0.01% 6178
2016
Q4 		$34K Buy
19
+9
+90% +$19.7K ﹤0.01% 6093
2016
Q3 		$25K Sell
10
-12
-55% -$29.6K ﹤0.01% 6039
2016
Q2 		$54K Buy
22
+5
+29% +$16.4K ﹤0.01% 5799
2016
Q1 		$60K Sell
17
-15
-47% -$52.1K ﹤0.01% 5713
2015
Q4 		$146K Sell
32
-60
-65% -$196K ﹤0.01% 5556
2015
Q3 		$148K Buy
92
+14
+18% +$70K ﹤0.01% 5492
2015
Q2 		$659K Buy
78
+11
+16% +$105K ﹤0.01% 4478
2015
Q1 		$672K Sell
67
-16
-19% -$147K ﹤0.01% 4081
2014
Q4 		$825K Buy
83
+52
+168% +$400K ﹤0.01% 4206
2014
Q3 		$252K Sell
31
-7
-18% -$66.1K ﹤0.01% 5181
2014
Q2 		$415K Buy
+38
New +$267K ﹤0.01% 4798

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America's IMUX Position: Q1 2026 in Review

Bank of America increased its Immunic (IMUX) stake by 79,828% in Q1 2026, buying an estimated $129K and bringing the position to 14,387 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #5430.

Bank of America first reported a position in IMUX in Q2 2014 and has held it in 47 quarters since. The position peaked at $825K in Q4 2014. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Bank of America held 14,387 shares of Immunic worth $160K as of Q1 2026.
  • Bank of America bought 14,369 Immunic shares in Q1 2026, an estimated $129K.
  • Immunic made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5430 holding.
  • Bank of America first reported a position in Immunic in Q2 2014 and has held it in 47 quarters since.
  • Bank of America's Immunic position peaked at $825K in Q4 2014.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.